메뉴 건너뛰기




Volumn 16, Issue 6, 2006, Pages 487-496

Alkylating benzamides with melanoma cytotoxicity: Experimental chemotherapy in a mouse melanoma model

Author keywords

Anticancer drugs; Experimental chemotherapy; Mouse melanoma model; N (2 dialkylaminoethyl)benzamide conjugates; Targeted melanoma therapy

Indexed keywords

4 [4 [4 [BIS(2 CHLOROETHYL)AMINO]PHENYL]BUTANAMIDO] N [2 (DIETHYLAMINO)ETHYL]BENZAMIDE; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BENZAMIDE DERIVATIVE; N,N' BIS[4 DIAZENYL N [2 (DIETHYLAMINO)ETHYL]BENZAMIDE]PIPERAZINE; PLACEBO;

EID: 33845591173     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cmr.0000232294.14408.6a     Document Type: Article
Times cited : (9)

References (29)
  • 1
    • 0031660951 scopus 로고    scopus 로고
    • Issues in the epidemiology of melanoma
    • Weinstock MA. Issues in the epidemiology of melanoma. Hematol Oncol Clin North Am 1998; 12:681-698.
    • (1998) Hematol Oncol Clin North Am , vol.12 , pp. 681-698
    • Weinstock, M.A.1
  • 2
    • 0030031511 scopus 로고    scopus 로고
    • Melanoma nodal metastases: Biological significance and therapeutic considerations
    • Reintgen D. Melanoma nodal metastases: biological significance and therapeutic considerations. Surg Oncol Clin North Am 1996; 5:105-120.
    • (1996) Surg Oncol Clin North Am , vol.5 , pp. 105-120
    • Reintgen, D.1
  • 3
    • 0002090268 scopus 로고
    • An analysis of prognostic factors in 8500 patients with cutaneous melanoma
    • Balch CM, Houghton AN, Milton GW, Sober AJ, Soong S-J, editors. Philadelphia: JB Lippincott
    • Balch CM, Soong S-j, Shaw HM, Urist MM, McCarthy WH. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong S-J, editors. Cutaneous melanoma. 2nd ed. Philadelphia: JB Lippincott, 1992. p. 165.
    • (1992) Cutaneous Melanoma. 2nd Ed. , pp. 165
    • Balch, C.M.1    Soong, S.-J.2    Shaw, H.M.3    Urist, M.M.4    McCarthy, W.H.5
  • 4
    • 0347503603 scopus 로고    scopus 로고
    • Palliative therapy of disseminated malignant melanoma: A systematic review of 41 randomised clinical trials
    • Eigentler TK, Caroli UM, Radny P, Garbe C. Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials. Lancet Oncol 2003; 4:748-759.
    • (2003) Lancet Oncol , vol.4 , pp. 748-759
    • Eigentler, T.K.1    Caroli, U.M.2    Radny, P.3    Garbe, C.4
  • 6
    • 0034936580 scopus 로고    scopus 로고
    • Melanocyte-directed enzyme prodrug therapy (MDEPT): Development of second generation prodrugs for targeted treatment of malignant melanoma
    • Jordan AM, Khan TH, Malkin H, Osborn HM, Photiou A, Riley PA. Melanocyte-directed enzyme prodrug therapy (MDEPT): development of second generation prodrugs for targeted treatment of malignant melanoma. Bioorg Med Chem 2001; 9:1549-1558.
    • (2001) Bioorg Med Chem , vol.9 , pp. 1549-1558
    • Jordan, A.M.1    Khan, T.H.2    Malkin, H.3    Osborn, H.M.4    Photiou, A.5    Riley, P.A.6
  • 7
    • 0028998282 scopus 로고
    • Antimelanoma effect of 4-S-cysteaminylcatechol-an activated form of 4-S-cysteaminylphenol
    • Inoue S, Hasegawa K, Ito S, Ozeki H, Solano F, Jimenez-Cervantes C, et al. Antimelanoma effect of 4-S-cysteaminylcatechol-an activated form of 4-S-cysteaminylphenol. Cancer Res 1995; 55:2603-2607.
    • (1995) Cancer Res , vol.55 , pp. 2603-2607
    • Inoue, S.1    Hasegawa, K.2    Ito, S.3    Ozeki, H.4    Solano, F.5    Jimenez-Cervantes, C.6
  • 8
    • 0043193607 scopus 로고
    • In vitro studies of 2,4-dihydroxyphenylalanine, a prodrug targeted against malignant melanoma cells
    • Morrison ME, Yagi MJ, Cohen G. In vitro studies of 2,4- dihydroxyphenylalanine, a prodrug targeted against malignant melanoma cells. Proc Natl Acad Sci USA 1985; 82:2960-2964.
    • (1985) Proc Natl Acad Sci USA , vol.82 , pp. 2960-2964
    • Morrison, M.E.1    Yagi, M.J.2    Cohen, G.3
  • 9
    • 0032560235 scopus 로고    scopus 로고
    • Therapeutic effects of monoclonal antibody-beta-lactamase conjugates in combination with a nitrogen mustard anticancer prodrug in models of human renal cell carcinoma
    • Svensson HP, Frank IS, Berry KK, Senter PD. Therapeutic effects of monoclonal antibody-beta-lactamase conjugates in combination with a nitrogen mustard anticancer prodrug in models of human renal cell carcinoma. J Med Chem 1998; 41:1507-1512.
    • (1998) J Med Chem , vol.41 , pp. 1507-1512
    • Svensson, H.P.1    Frank, I.S.2    Berry, K.K.3    Senter, P.D.4
  • 10
    • 0032808621 scopus 로고    scopus 로고
    • Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin
    • Rosenblum MG, Marks JW, Cheung LH. Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin. Cancer Chemother Pharmacol 1999; 44:343-348.
    • (1999) Cancer Chemother Pharmacol , vol.44 , pp. 343-348
    • Rosenblum, M.G.1    Marks, J.W.2    Cheung, L.H.3
  • 11
    • 0033230497 scopus 로고    scopus 로고
    • Comparison of recombinant and synthetically formed monoclonal antibody-beta-lactamase conjugates for anticancer prodrug activation
    • Kerr DE, Vrudhula VM, Svensson HP, Siemers NO, Senter PD. Comparison of recombinant and synthetically formed monoclonal antibody-beta-lactamase conjugates for anticancer prodrug activation. Bioconjug Chem 1999; 10:1084-1089.
    • (1999) Bioconjug Chem , vol.10 , pp. 1084-1089
    • Kerr, D.E.1    Vrudhula, V.M.2    Svensson, H.P.3    Siemers, N.O.4    Senter, P.D.5
  • 12
    • 0028177662 scopus 로고
    • Receptor mediated cytotoxicity of a-MSH fragments containing melphalan in a human melanoma cells line
    • Morandini R, Suli-Vargha H, Libert A, Loir B, Botyanszki J, Medzihradszky K, et al. Receptor mediated cytotoxicity of a-MSH fragments containing melphalan in a human melanoma cells line. Int J Cancer 1994; 56:129-133.
    • (1994) Int J Cancer , vol.56 , pp. 129-133
    • Morandini, R.1    Suli-Vargha, H.2    Libert, A.3    Loir, B.4    Botyanszki, J.5    Medzihradszky, K.6
  • 14
    • 0027317379 scopus 로고
    • Phase II scintigraphic clinical trial of malignant melanoma with iodine- 123-N-(2-diethylaminoethyl-4-iodobenzamide)
    • Michelot JM, Moreau MCF, Veyre AJ, Bonafous JF, Bacin FJ, Madelmont JC, et al. Phase II scintigraphic clinical trial of malignant melanoma with iodine- 123-N-(2-diethylaminoethyl-4-iodobenzamide). J Nucl Med 1993; 34:1260-1266.
    • (1993) J Nucl Med , vol.34 , pp. 1260-1266
    • Michelot, J.M.1    Moreau, M.C.F.2    Veyre, A.J.3    Bonafous, J.F.4    Bacin, F.J.5    Madelmont, J.C.6
  • 16
    • 0034687239 scopus 로고    scopus 로고
    • Radioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: Structure-affinity relationships, metabolic fate, and intracellular localization
    • Eisenhut M, Hull WE, Mohammed A, Mier W, Lay D, Just W, et al. Radioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization. J Med Chem 2000; 43:3913-3922.
    • (2000) J Med Chem , vol.43 , pp. 3913-3922
    • Eisenhut, M.1    Hull, W.E.2    Mohammed, A.3    Mier, W.4    Lay, D.5    Just, W.6
  • 18
    • 27644518128 scopus 로고    scopus 로고
    • Alkylating benzamides with melanoma cytotoxicity; Role of melanin, tyrosinase, intracellular pH and DNA interaction
    • Wolf M, Bauder-Wüst U, Mier W, Haberkorn U, Eisenhut M. Alkylating benzamides with melanoma cytotoxicity; Role of melanin, tyrosinase, intracellular pH and DNA interaction. Melanoma Res 2005; 15:383-391.
    • (2005) Melanoma Res , vol.15 , pp. 383-391
    • Wolf, M.1    Bauder-Wüst, U.2    Mier, W.3    Haberkorn, U.4    Eisenhut, M.5
  • 19
    • 0035028492 scopus 로고    scopus 로고
    • Preclinical targeted alpha therapy for subcutaneous melanoma
    • Allen BJ, Rizvi SMA, Tian Z. Preclinical targeted alpha therapy for subcutaneous melanoma. Melanoma Res 2001; 11:175-182.
    • (2001) Melanoma Res , vol.11 , pp. 175-182
    • Allen, B.J.1    Rizvi, S.M.A.2    Tian, Z.3
  • 20
    • 0018899745 scopus 로고
    • Response to chemotherapy of human, malignant melanoma xenografts in athymic, nude mice
    • Fodstad O, Aass N, Pihl A. Response to chemotherapy of human, malignant melanoma xenografts in athymic, nude mice. Int J Cancer 1980; 25:453-458.
    • (1980) Int J Cancer , vol.25 , pp. 453-458
    • Fodstad, O.1    Aass, N.2    Pihl, A.3
  • 22
    • 0035678873 scopus 로고    scopus 로고
    • Role of cytochrome P450 isoenzymes in metabolism of O(6)-benzylguanine: Implications for dacarbazine activation
    • Long L, Dolan ME. Role of cytochrome P450 isoenzymes in metabolism of O(6)-benzylguanine: implications for dacarbazine activation. Clin Cancer Res 2001; 7:4239-4244.
    • (2001) Clin Cancer Res , vol.7 , pp. 4239-4244
    • Long, L.1    Dolan, M.E.2
  • 24
    • 13244253993 scopus 로고    scopus 로고
    • Effect of 2-amino-2-[2-(4-octylphenyl)ethyl] propane-1,3-diol hydrochloride (FTY 720) on liver injury in mice
    • He JH, Zhang HN, Lin ZB. Effect of 2-amino-2-[2-(4-octylphenyl)ethyl] propane-1,3-diol hydrochloride (FTY 720) on liver injury in mice. World J Gastroenterol 2005; 11:573-576.
    • (2005) World J Gastroenterol , vol.11 , pp. 573-576
    • He, J.H.1    Zhang, H.N.2    Lin, Z.B.3
  • 25
    • 0036208833 scopus 로고    scopus 로고
    • Temozolomide and whole brain irradiation in melanoma metastatic to the brain: A phase II trial of the Cytokine Working Group
    • Margolin K, Atkins B, Thompson A, Ernstoff S, Weber J, Flaherty L, et al. Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group. J Cancer Res Clin Oncol 2002; 128:214-218.
    • (2002) J Cancer Res Clin Oncol , vol.128 , pp. 214-218
    • Margolin, K.1    Atkins, B.2    Thompson, A.3    Ernstoff, S.4    Weber, J.5    Flaherty, L.6
  • 26
    • 33645275176 scopus 로고    scopus 로고
    • Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanomas
    • Bajetta E, Del Vecchio M, Nova P, Fusi A, Daponte A, Sertoli MR, et al. Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanomas. Ann Oncol 2006; 17:571-577.
    • (2006) Ann Oncol , vol.17 , pp. 571-577
    • Bajetta, E.1    Del Vecchio, M.2    Nova, P.3    Fusi, A.4    Daponte, A.5    Sertoli, M.R.6
  • 27
    • 21744439869 scopus 로고    scopus 로고
    • Treatment of metastatic malignant melanoma
    • Atallah E, Flaherty L. Treatment of metastatic malignant melanoma. Curr Treat Options Oncol 2005; 6:185-193.
    • (2005) Curr Treat Options Oncol , vol.6 , pp. 185-193
    • Atallah, E.1    Flaherty, L.2
  • 28
    • 3242798965 scopus 로고    scopus 로고
    • Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma
    • Kim KB, Eton O, East MJ, Hodges C, Papadopoulos NE, Grimm EA, et al. Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma. Cancer 2004; 101:596-603.
    • (2004) Cancer , vol.101 , pp. 596-603
    • Kim, K.B.1    Eton, O.2    East, M.J.3    Hodges, C.4    Papadopoulos, N.E.5    Grimm, E.A.6
  • 29
    • 0029782311 scopus 로고    scopus 로고
    • Endogenous interleukin 6 levels in patients with metastatic malignant melanoma: Correlation with tumor burden
    • Mouawad R, Benhammouda A, Rixe O, Antoine EC, Borel C, Weil M, et al. Endogenous interleukin 6 levels in patients with metastatic malignant melanoma: correlation with tumor burden. Clin Cancer Res 1996; 2:1405-1409.
    • (1996) Clin Cancer Res , vol.2 , pp. 1405-1409
    • Mouawad, R.1    Benhammouda, A.2    Rixe, O.3    Antoine, E.C.4    Borel, C.5    Weil, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.